Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making.

For nanotechnology to meet its potential as a game-changing and sustainable technology, it is important to ensure that the engineered nanomaterials and nanoenabled products that gain entry to the marketplace are safe and effective. Tools and methods are needed for regulatory purposes to allow rapid material categorization according to human health and environmental risk potential, so that materials of high concern can be targeted for additional scrutiny, while material categories that pose the least risk can receive expedited review. Using carbon nanotubes as an example, we discuss how data from alternative testing strategies can be used to facilitate engineered nanomaterial categorization according to risk potential and how such an approach could facilitate regulatory decision-making in the future.

[1]  Wojciech Zareba,et al.  Ambient fine particulate air pollution triggers ST-elevation myocardial infarction, but not non-ST elevation myocardial infarction: a case-crossover study , 2014, Particle and Fibre Toxicology.

[2]  Xiang Wang,et al.  Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.

[3]  T. Xia,et al.  Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. , 2012, Nano letters.

[4]  Thomas Hartung,et al.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. , 2013, ALTEX.

[5]  Reinhard Kreiling,et al.  A critical appraisal of existing concepts for the grouping of nanomaterials. , 2014, Regulatory toxicology and pharmacology : RTP.

[6]  Peter Wick,et al.  Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials. , 2013, Accounts of chemical research.

[7]  Lang Tran,et al.  ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy , 2014, Particle and Fibre Toxicology.

[8]  Jo Anne Shatkin,et al.  A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. , 2013, ACS nano.

[9]  Guidance on information requirements and chemical safety assessment , 2008 .

[10]  U. Epa,et al.  Office of Pollution Prevention and Toxics , 2000 .

[11]  Zongxi Li,et al.  Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity. , 2013, ACS nano.

[12]  Significant New Use Rules on Certain Chemical Substances ( Final Rule ) Related News , 2022 .

[13]  Steffen Foss Hansen,et al.  Categorization framework to aid hazard identification of nanomaterials , 2007 .

[14]  Rong Liu,et al.  Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology. , 2013, Small.

[15]  Vincent Castranova,et al.  Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. , 2011, ACS nano.

[16]  P. Baron,et al.  Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[17]  Meiying Wang,et al.  Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. , 2015, ACS nano.